Article
Emerging Cellular Therapies for Cancer
11 Dec 2018
Abstract excerpt
Genetically engineered T cells are powerful new medicines, offering hope for curative responses in patients with cancer. Chimeric antigen receptor (CAR) T cells were recently approved by the US Food and Drug Administration and are poised to enter the practice of medicine for leukemia and lymphoma, demonstrating that engineered immune cells can serve as a powerful new class of cancer therapeutics. The emergence of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
